B+
Bull case
25%
Probability
Target price
$190.00
Analysis reference price unavailable
Analysis 2026-09-29 · RankAlpha Sentiment Codex
ALGN
AlignCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
45%
Probability
Target price
$160.00
Analysis reference price unavailable
Analysis 2026-09-29 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$105.00
Analysis reference price unavailable
Analysis 2026-09-29 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-29
Recent news sentiment (30D)
-26.0
Negative
Company
-
Unavailable
Macro
-26.0
Negative
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+54.9
Score
AI commentary
News is mixed: company-reported aligner growth contrasts with scanner weakness and softer near-term guidance. A secondary September article reports a post-earnings share decline, but the packet does not establish a verified immediate reaction, consensus surprise, or subsequent analyst revisions. The August 31 board-election filing is not an operating catalyst. [#8-K-2026-08-31] Sentiment fields shown as zero are unavailable observations, not neutral readings; social coverage is insufficient.
RankAlpha Sentiment Codex - 2026-09-29
Open full AI memoEvidence flagged
peer set is too generic or lacks enough direct operating comparators
Impact
tentative
Confidence
-
AI events
2026-10-31catalystQ3 revenue and aligner-volume testHigh impact
Align guided to Q3 revenue of $1.00–$1.02 billion, mid-single-digit year-over-year Clear Aligner volume growth, and approximately 24% non-GAAP operating margin. Results will test whether aligner growth offsets weaker scanner economics. The reporting date is unconfirmed; the date below is a monitoring estimate. [#SEC-8K-2026-07-29] SEC earnings exhibit
2026-12-31eventScanner placements versus scanner revenueHigh impact
Management expects double-digit 2026 iTero shipment growth but a 6%–8% decline in Systems and Services revenue as lower-priced scanners and leasing or rental models change the mix. Evidence that placements subsequently support Invisalign case growth would strengthen the platform thesis; continued revenue erosion would weaken it. [#SEC-8K-2026-07-29] SEC earnings exhibit
2027-12-31catalyst2027 margin-improvement targetHigh impact
Management preliminarily targeted at least approximately 100 basis points of further GAAP and non-GAAP operating-margin improvement in 2027, but explicitly said this was not formal guidance. A later strategic-review update and delivery against that target would be more meaningful than the aspiration alone. [#SEC-8K-2026-07-29] SEC earnings exhibit
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-29 • Updated nightlySource: Internal modelMethodology